| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |